Figure 4From: Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension Influence of BMPR2 mutation types on clinical outcomes of PAH patients. Time to death or lung transplantation in BMPR2 missense mutation carriers, BMPR2 truncating mutation carriers and patients carriers of a large rearrangement or a splice defect. BMPR2: bone morphogenetic protein receptor type 2.Back to article page